Physics and biology have come together to solve one of science's big issues - the structure of membrane proteins - through the ARC Centre of Excellence for Coherent X-ray Science.

Speedy laser facility will be used for biological imaging.

BioPharmica intends to offer an IPO on one of its spin-off companies, Cortical Dynamics.

Melbourne's Swinburne University of Technology has developed a rapid method for the analysis of microorganisms on CD or DVD which could be used to detect bioterror agents.

The nanotech sector in Australia is growing with potential.

The Centre for Neuropsychology at Swinburne University of Technology will conduct an independent study, subject to ethical approval, for botanical biotech Solagran (ASX:SLA) to examine the neuro-cognitive, mood and brain EEG effects of Bioeffective R.

After raising AUD$2.6 million from its August float, new Perth biomedical company BioPharmica (ASX:BPH) has been busy trawling Australian research waters for new intellectual property.

A new service has been established to give researchers and biotechnology companies access to drug discovery and bioinformatics tools.

The biocatalysis group at CSIRO Molecular Science, led by Prof Michael Zachariou, has established an impressive pipeline of research and is working towards developing a more sustainable and renewable chemical industry in Australia, writes Susan Williamson.